Market icon

JN.1 most common COVID variant in US by Dec 23?

Market icon

JN.1 most common COVID variant in US by Dec 23?

>99% chance
Polymarket

$3,923 Vol.

>99% chance
Polymarket

$3,923 Vol.

This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
볼륨
$3,923
종료일
Dec 23, 2023
생성일
Dec 19, 2023, 12:57 PM ET
This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.

제안된 결과: Yes

이의 없음

최종 결과: Yes

This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
볼륨
$3,923
종료일
Dec 23, 2023
생성일
Dec 19, 2023, 12:57 PM ET
This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.

제안된 결과: Yes

이의 없음

최종 결과: Yes

외부 링크를 조심하십시오.

Frequently Asked Questions

"JN.1 most common COVID variant in US by Dec 23?" is a prediction market on Polymarket where traders buy and sell "Yes" or "No" shares based on whether they believe this event will happen. The current crowd-sourced probability is 100% for "Yes." For example, if "Yes" is priced at 100¢, the market collectively assigns a 100% chance that this event will occur. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"JN.1 most common COVID variant in US by Dec 23?" is a newly created market on Polymarket, launched on Dec 19, 2023. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "JN.1 most common COVID variant in US by Dec 23?," simply choose whether you believe the answer is "Yes" or "No." Each side has a current price that reflects the market's implied probability. Enter your amount and click "Trade." If you buy "Yes" shares and the outcome resolves as "Yes," each share pays out $1. If it resolves as "No," your "Yes" shares pay $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current probability for "JN.1 most common COVID variant in US by Dec 23?" is 100% for "Yes." This means the Polymarket crowd currently believes there is a 100% chance that this event will occur. These odds update in real-time based on actual trades, providing a continuously updated signal of what the market expects to happen.

The resolution rules for "JN.1 most common COVID variant in US by Dec 23?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.